Study In Healthy Subjects To Evaluate The Photo-Irritant Potential Of Eltrombopag

Clinical trial NCT00688272 · COMPLETED

Trial details

NCT number: NCT00688272
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Purpura, Thrombocytopaenic, Idiopathic

Start date: 2008-06-02
Primary completion: 2008-09-25
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.